Motor Performance After Treatment for XXXX .

@entity5 @entity1 @entity735 @entity3478
BACKGROUND: Reduced motor performance can negatively affect physical activity and social partake after @entity5 . Especially in @entity3478 @entity1 , who are at risk of physical limitations due to surgical interventions, motor performance has not yet been sufficiently investigated. Therefore, this study aimed at assessing motor performance in pediatric @entity3478 @entity1 . PROCEDURE: Motor performance was measured within 2 years posttreatment using the MOON (test for MOtor performance in pediatric ONcology) test. This instrument enables quantitative data collection even in physically impaired @entity1 for comparison with age-matched and sex-matched reference values. RESULTS: Twenty-one @entity1 (13 male) ages 15.2  2.1 years (median: 15 y, 10 to 19 y) and 9.4  7.4 months posttreatment (median: 6 mo, 2 to 24 mo) were tested. Motor performance was slightly reduced in muscular endurance of the legs; significantly reduced in speed, flexibility, @entity735 , and muscular explosive strength (P<0.001), whereas @entity1 ' hand grip strength and static balance were superior to the reference values. Follow-up duration, body mass index, and @entity5 localization apparently affected motor performance. CONCLUSIONS: These findings show serious reductions in motor performance within 2 years after @entity3478 treatment and highlight the need for interventions to improve motor performance. The results should be used to advise and support @entity1 to engage in suitable physical and sports activities.
